113 related articles for article (PubMed ID: 31885098)
21. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
[TBL] [Abstract][Full Text] [Related]
22. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase.
Hiratsuka S; Watanabe A; Sakurai Y; Akashi-Takamura S; Ishibashi S; Miyake K; Shibuya M; Akira S; Aburatani H; Maru Y
Nat Cell Biol; 2008 Nov; 10(11):1349-55. PubMed ID: 18820689
[TBL] [Abstract][Full Text] [Related]
23. S100A8/A9 in Inflammation.
Wang S; Song R; Wang Z; Jing Z; Wang S; Ma J
Front Immunol; 2018; 9():1298. PubMed ID: 29942307
[TBL] [Abstract][Full Text] [Related]
24. The antimicrobial heterodimer S100A8/S100A9 (calprotectin) is upregulated by bacterial flagellin in human epidermal keratinocytes.
Abtin A; Eckhart L; Gläser R; Gmeiner R; Mildner M; Tschachler E
J Invest Dermatol; 2010 Oct; 130(10):2423-30. PubMed ID: 20555353
[TBL] [Abstract][Full Text] [Related]
25. High expression of S100 calgranulin genes in peripheral blood mononuclear cells from patients with Takayasu arteritis.
Kabeerdoss J; Thomas M; Goel R; Mohan H; Danda S; L J; Danda D
Cytokine; 2019 Feb; 114():61-66. PubMed ID: 30594066
[TBL] [Abstract][Full Text] [Related]
26. Phagocyte-specific S100A8/A9 is upregulated in primary Sjögren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
Nicaise C; Weichselbaum L; Schandene L; Gangji V; Dehavay F; Bouchat J; Balau B; Vogl T; Soyfoo MS
Clin Exp Rheumatol; 2017; 35(1):129-136. PubMed ID: 27749214
[TBL] [Abstract][Full Text] [Related]
27. Advanced glycation end-products and Porphyromonas gingivalis lipopolysaccharide increase calprotectin expression in human gingival epithelial cells.
Hiroshima Y; Sakamoto E; Yoshida K; Abe K; Naruishi K; Yamamoto T; Shinohara Y; Kido JI; Geczy CL
J Cell Biochem; 2018 Feb; 119(2):1591-1603. PubMed ID: 28771806
[TBL] [Abstract][Full Text] [Related]
28. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
29. IL-6 stimulation of DNA replication is JAK1/2 mediated in cross-talk with hyperactivated ERK1/2 signaling.
Subotički T; Mitrović Ajtić O; Beleslin-Čokić BB; Bjelica S; Djikić D; Diklić M; Leković D; Gotić M; Santibanez JF; Noguchi CT; Čokić VP
Cell Biol Int; 2019 Feb; 43(2):192-206. PubMed ID: 30571852
[TBL] [Abstract][Full Text] [Related]
30. A20, an essential component of the ubiquitin-editing protein complex, is a negative regulator of inflammation in human myometrium and foetal membranes.
Lappas M
Mol Hum Reprod; 2017 Sep; 23(9):628-645. PubMed ID: 28911210
[TBL] [Abstract][Full Text] [Related]
31. Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells via glucocorticoid receptor β and S100A8/9 up-regulation.
Wang Z; Zheng G; Li G; Wang M; Ma Z; Li H; Wang XY; Yi H
J Cell Mol Med; 2020 Dec; 24(23):13703-13714. PubMed ID: 33094923
[TBL] [Abstract][Full Text] [Related]
32. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.
Cormier K; Harquail J; Ouellette RJ; Tessier PA; Guerrette R; Robichaud GA
Anticancer Agents Med Chem; 2014 Jan; 14(1):35-45. PubMed ID: 24041228
[TBL] [Abstract][Full Text] [Related]
33. The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients.
Lau WW; Hannah R; Green AR; Göttgens B
Blood; 2015 Mar; 125(10):1679-81. PubMed ID: 25745188
[No Abstract] [Full Text] [Related]
34. Investigating the extremes of the continuum of paracrine functions in CD34-/CD31+ CACs across diverse populations.
Landers-Ramos RQ; Sapp RM; VandeWater E; Macko J; Robinson S; Wang Y; Chin ER; Spangenburg EE; Prior SJ; Hagberg JM
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H162-H172. PubMed ID: 27793853
[TBL] [Abstract][Full Text] [Related]
35. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
Nakajima Y; Inagaki Y; Kido J; Nagata T
Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
[TBL] [Abstract][Full Text] [Related]
36. S100A8 contributes to postoperative cognitive dysfunction in mice undergoing tibial fracture surgery by activating the TLR4/MyD88 pathway.
Lu SM; Yu CJ; Liu YH; Dong HQ; Zhang X; Zhang SS; Hu LQ; Zhang F; Qian YN; Gui B
Brain Behav Immun; 2015 Feb; 44():221-34. PubMed ID: 25449673
[TBL] [Abstract][Full Text] [Related]
37. The hetero-oligomeric complex of the S100A8/S100A9 protein is extremely protease resistant.
Nacken W; Kerkhoff C
FEBS Lett; 2007 Oct; 581(26):5127-30. PubMed ID: 17936757
[TBL] [Abstract][Full Text] [Related]
38. The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis.
Cerezo LA; Remáková M; Tomčik M; Gay S; Neidhart M; Lukanidin E; Pavelka K; Grigorian M; Vencovský J; Šenolt L
Rheumatology (Oxford); 2014 Aug; 53(8):1520-6. PubMed ID: 24643522
[TBL] [Abstract][Full Text] [Related]
39. IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts.
Carrión M; Juarranz Y; Martínez C; González-Álvaro I; Pablos JL; Gutiérrez-Cañas I; Gomariz RP
Rheumatology (Oxford); 2013 Dec; 52(12):2177-86. PubMed ID: 24056519
[TBL] [Abstract][Full Text] [Related]
40. AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes.
Takano APC; Senger N; Munhoz CD; Barreto-Chaves MLM
Pflugers Arch; 2018 Mar; 470(3):549-558. PubMed ID: 29178049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
